Koert Vandenenden - Net Worth and Insider Trading
Koert Vandenenden Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Koert Vandenenden owns 1 companies in total, including Arbutus Biopharma Corp (ABUS) .
Click here to see the complete history of Koert Vandenenden’s form 4 insider trades.
Insider Ownership Summary of Koert Vandenenden
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
ABUS | Arbutus Biopharma Corp | 2018-12-11 | Chief Accounting Officer |
Koert Vandenenden Trading Performance
Koert Vandenenden Ownership Network
Koert Vandenenden Owned Company Details
What does Arbutus Biopharma Corp do?
Who are the key executives at Arbutus Biopharma Corp?
Koert Vandenenden is the Chief Accounting Officer of Arbutus Biopharma Corp. Other key executives at Arbutus Biopharma Corp include Chief Financial Officer David C Hastings , Chief Business Officer Michael J. Mcelhaugh , and Chief Scientific Officer Michael J. Sofia .
Arbutus Biopharma Corp (ABUS) Insider Trades Summary
Over the past 18 months, Koert Vandenenden made no insider transaction in Arbutus Biopharma Corp (ABUS). Other recent insider transactions involving Arbutus Biopharma Corp (ABUS) include a net sale of 10,164 shares made by Michael J. Mcelhaugh , a net sale of 9,982 shares made by Michael J. Sofia , and a net sale of 9,593 shares made by David C Hastings .
In summary, during the past 3 months, insiders sold 8,846 shares of Arbutus Biopharma Corp (ABUS) in total and bought 0 shares, with a net sale of 8,846 shares. During the past 18 months, 42,943 shares of Arbutus Biopharma Corp (ABUS) were sold and 0 shares were bought by its insiders, resulting in a net sale of 42,943 shares.
Arbutus Biopharma Corp (ABUS)'s detailed insider trading history can be found in Insider Trading Tracker table.
Arbutus Biopharma Corp Insider Transactions
Koert Vandenenden Mailing Address
Above is the net worth, insider trading, and ownership report for Koert Vandenenden. You might contact Koert Vandenenden via mailing address: C/o Arbutus Biopharma Corp., Suite 100, 8900 Glenlyon Parkway, Burnaby A1 V5j 5j8.